Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Tsukinowacho, Seta, Otsu City, Shiga, 520-2192, Japan.
Cancer Immunol Immunother. 2024 Sep 5;73(11):212. doi: 10.1007/s00262-024-03800-8.
Patients with lung cancer have a high incidence of tumor recurrence even after curative surgical resection. Some reports indicated that immunosuppressive cells induced by surgical stress could contribute to tumor recurrence after surgery; however, the underlying mechanisms are not fully understood. In this study, we found that increased postoperative blood monocytes served as a risk factor for tumor recurrence in 192 patients with non-small cell lung cancer (NSCLC). We established the lung cancer recurrent mouse model after tumor resection and showed that the surgical stress immediately increased the level of serum monocyte chemoattractant protein-1 (MCP-1), which subsequently increased blood monocytes. These blood monocytes were rapidly recruited into distant micrometastases and became tumor growth-promoting tumor associated macrophages (TAMs). Furthermore, even after the blood MCP-1 and monocytes decreased enough 72 h after tumor resection, TAMs in micrometastases remained rich because the MCP-1 secreted by micrometastases themselves continued to recruit monocytes around the tumor. Consequently, tumor resection triggered the outgrowth of distant metastases via the MCP-1-Monocyte-TAM axis. When we administered the MCP-1 inhibitor to the lung cancer recurrent model mice, blood monocytes decreased after tumor resection, and TAMs in micrometastases also dramatically decreased. Finally, peri- and postoperative treatment with the MCP-1 inhibitor suppressed distant metastases after surgery. Targeting the MCP-1-Monocyte-TAM axis may inhibit surgical stress-induced NSCLC recurrence by attenuating postoperative immunosuppressive monocytes in micrometastases.
肺癌患者即使经过根治性手术切除,仍有很高的肿瘤复发率。一些报道表明,手术应激诱导的免疫抑制细胞可能导致手术后肿瘤复发;然而,其潜在机制尚不完全清楚。在这项研究中,我们发现 192 例非小细胞肺癌(NSCLC)患者术后血单核细胞增多是肿瘤复发的危险因素。我们建立了肿瘤切除后的肺癌复发小鼠模型,结果表明手术应激立即增加了血清单核细胞趋化蛋白-1(MCP-1)的水平,进而增加了血单核细胞。这些血单核细胞迅速招募到远处的微转移灶,并成为促进肿瘤生长的肿瘤相关巨噬细胞(TAMs)。此外,即使在肿瘤切除后 72 小时血 MCP-1 和单核细胞减少足够时,由于微转移灶自身分泌的 MCP-1 继续招募肿瘤周围的单核细胞,微转移灶中的 TAMs 仍然丰富。因此,肿瘤切除通过 MCP-1-单核细胞-TAM 轴触发了远处转移的生长。当我们在肺癌复发模型小鼠中给予 MCP-1 抑制剂时,肿瘤切除后血单核细胞减少,微转移灶中的 TAMs 也显著减少。最后,围手术期应用 MCP-1 抑制剂抑制了手术后的远处转移。靶向 MCP-1-单核细胞-TAM 轴可能通过减弱微转移灶中术后免疫抑制性单核细胞来抑制手术应激诱导的 NSCLC 复发。